Purpose: During the 1980s and 1990s the number, incidence rate and proporti
on of moderately differentiated prostate cancer cases ascertained by popula
tion based cancer registries increased substantially. The increase is thoug
ht to have resulted from the widespread use of prostate specific antigen (P
SA) for screening because it occurred coincidentally with the introduction
of PSA for early detection of prostate cancer. We investigate this increase
in a population based study.
Materials and Methods: To report the trends in tumor grade we conducted a b
linded, standardized pathological study and reviewed medial records of a st
ratified random sample of cases diagnosed before and after the introduction
of PSA (1983 to 1984 and 1992 to 1993). Archival tumor biopsy specimens or
transurethral resection of the prostate specimens were reviewed for the di
agnosis of cancer and assignment of Gleason score. Medical records were rev
iewed to determine the method of prostate cancer detection for each case.
Results: We found a small but statistically insignificant shift in the dist
ribution of Gleason scores assigned after review of biopsy or transurethral
resection specimens. The proportion of Gleason score 2, 3 and 4 tumors dec
reased, and the proportion of 7, 8, 9 and 10 tumors as a group did not chan
ge. The shifts in Gleason score resulted in a slight statistically nonsigni
ficant increase in mean Gleason score. There was a significant shift in the
method of detection from predominately incidental detection in the earlier
period to predominately screen detection in the later period. Because the
proportion of screen detected tumors increased and they had a significantly
higher mean Gleason scare than incidentally detected tumors within each in
terval, the overall mean Gleason score increased.
Conclusions: After a standardized pathological review a small shift in the
distribution of Gleason scores occurred resulting in a small increase in me
an Gleason score between 1983 and 1984, and 1992 and 1993. There was little
change in the proportion of Gleason score 7, 8, 9 and 10 tumors between th
e 2 periods.